Anebulo Pharmaceuticals (ANEB) Non-Current Assets (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Non-Current Assets of $148,231 for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 66.7% from $445,731 a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Non-Current Assets (2021 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals posted Non-Current Assets of $183,110, down 67.6% from FY2024.
- By fiscal year, Non-Current Assets came in at $565,124 in FY2024.
- The fiscal Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to fiscal Q3 2021.
- Year over year, Non-Current Assets has now declined in each of the last five quarters, with an average decline of 60.9% over the last five quarters.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $165,670 (Q1 2026), $183,110 (Q4 2025) and $200,549 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Anebulo Pharmaceuticals | 12.74 Mn | -31.57 Mn | - | 148,231.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 148,231.00 |
| Sep 30, 2025 | 165,670.00 |
| Jun 30, 2025 | 183,110.00 |
| Mar 31, 2025 | 200,549.00 |
| Dec 31, 2024 | 445,731.00 |
| Sep 30, 2024 | 505,427.00 |
| Jun 30, 2024 | 565,124.00 |
| Mar 31, 2024 | 624,820.00 |
| Dec 31, 2023 | 684,516.00 |
| Mar 31, 2021 | 392,730.00 |
API Access
Anebulo Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();